PCI Pharma Services Expands U.S. Sterile Manufacturing and Drug-Device Capabilities in $1B+ Global Investment Program

URLhttps://www.citybiz.co/article/837379/pci-pharma-s
SourceCity Biz
Date Published04/27/2026

Additional Reshoring Information:

Company/Division name PCI Pharma Services
Parent companyPCI Pharma Services
Type of work Manufacturing
If manufacturing, is the company a contract manufacturer?Yes
Reshoring category:Reshoring
Year reshoring announced:2026
Domestically, the work will be done:In-house
Capital investment ($):1000
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredDrug Devices
What domestic positive factors made reshoring more attractive?Eco-system synergies
Find Reshoring Articles